Marksans Pharma LimitedNSE: MARKSANS

Press Release Mar 10 2023

· Issued by Marksans Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-10-2023-7

Marksans Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases